Dose-Response Relationship, RadiationUltraviolet RaysNeoplasmsRadiation DosageRadiation InjuriesRadiation, IonizingRadiation ToleranceCarcinogensRadiationCell Line, TumorRadiotherapyRadiation ProtectionAntineoplastic AgentsRadiotherapy DosageRadiation MonitoringRadiation OncologyCombined Modality TherapyCell Transformation, NeoplasticApoptosisAneuploidyRadiotherapy, ConformalCell SurvivalXenograft Model Antitumor AssaysRadiotherapy, Intensity-ModulatedRisk AssessmentRadiation PneumonitisNeoplasms, Radiation-InducedDose FractionationRadiotherapy, AdjuvantOncolytic VirotherapyRadiotherapy Planning, Computer-AssistedBreast NeoplasmsDrug Screening Assays, AntitumorRisk FactorsProstatic NeoplasmsRadiation Injuries, ExperimentalRadiometryCell DeathCosmic RadiationGamma RaysBrachytherapyRadiation-Sensitizing AgentsLung NeoplasmsEarly Detection of CancerNeoplasm Recurrence, LocalNeoplasm StagingCarcinoma, Squamous CellHead and Neck NeoplasmsTreatment OutcomeRetrospective StudiesSurvival AnalysisRadiosurgerySurvival RateAntineoplastic Combined Chemotherapy ProtocolsBrain NeoplasmsBackground RadiationPrognosisFollow-Up StudiesNeoplasm MetastasisOvarian NeoplasmsRadiation-Protective AgentsGene Expression Regulation, NeoplasticRadiotherapy, Computer-AssistedDisease-Free SurvivalPancreatic NeoplasmsMice, NudeCranial IrradiationParticle AcceleratorsRadiodermatitisColonic NeoplasmsRadiation EffectsNeoplasm InvasivenessRadiotherapy, Image-GuidedAdenocarcinomaStomach NeoplasmsUterine Cervical NeoplasmsCarcinoma, Non-Small-Cell LungMalpighian TubulesCarcinomaRadiotherapy, High-EnergyTime FactorsCobalt RadioisotopesCisplatinTumor BurdenRectal NeoplasmsTomography, X-Ray ComputedDNA DamageChemoradiotherapyOrgans at RiskRadiobiologyTumor Markers, BiologicalNeoplasm ProteinsGene Expression ProfilingProspective StudiesProstate-Specific AntigenFluorouracilX-RaysRiskMutationSurvivors